MedTrace Logo

Edessy ICSI Outcome Embryo Score (EIOS) Efficacy

NCT02082288 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 243

Last updated 2015-01-26

Study results available
· View outcomes & findings →

Summary

Purpose of this study is to detect outcome of intracytoplasmic sperm injection (ICSI) according to EIOS

Conditions

Interventions

OTHER

Edessy ICSI Outcome Embryo Score

EIOS: Age (ys) \>35 (0) 30-35 (1) \<30 (2) No of retrived oocyte \<5 (0) 5-9 (1) ≥ 10 (2) No of EC embryos \<2 (0) 2-4 (1) \>4 (2) No of good quality embryos \<3 (0) 3-5 (1) \>5 (2) No of embryos transferred -------- (0) ≤2 (1) \>2 (2)

Sponsors & Collaborators

  • Al-Azhar University

    lead OTHER

Principal Investigators

  • Mahmoud Edessy, MD · Al-Azhar University

  • Abd-Elnasr M Ali, MD · Al-Azhar University

  • Ahmed Fata, MD · Al-Azhar University

  • Wael M Hamed, MSc · Al-Azhar University

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-12-31
Primary Completion
2012-09-30
Completion
2012-09-30

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02082288 on ClinicalTrials.gov